This week, value and momentum are taking center stage as investors sift through opportunities in sectors both steady and fast-moving.
From under-the-radar setups to quietly building growth stories, the market is serving up a mix of bargain-bin bargains and potential breakout plays.
Wealth Trigger List (Sponsored)
The difference between “nice returns” and life-changing gains often comes down to timing—and information.
Our latest research has identified 5 stocks positioned for massive growth.
These companies combine strong fundamentals with technical setups that suggest the potential for explosive upside.
Past editions of this same report have included stocks that went on to gain +175%, +498%, even +673%.¹
While the past can’t predict the future, the track record speaks volumes.
For a limited time, you can download the full 5 Stocks Set to Double report—absolutely free.
[Get your free copy before midnight tonight]
Smart investors know: when the window is short, action beats hesitation.
*This free resource is being sent by Zacks. We identify investment resources you may choose to use in making your own decisions. Use of this resource is subject to the Zacks Terms of Service.
*Past performance is no guarantee of future results. Investing involves risk. This material does not constitute investment, legal, accounting, or tax advice. Zacks Investment Research is not a licensed dealer, broker, or investment adviser.
Don’t Let These Undervalued Stocks Slip Through Your Fingers!
We now send our favorite value picks via text, too, so you’ll get the same actionable news without having to open your inbox.
Retail
Footwear Underdog Quietly Becomes a Market Sprinter
Genesco (NYSE: GCO) has been quietly outperforming lately, with shares surging 29% over the past four weeks and nearly 49% over the last 12 months.
Not exactly the sluggish footwear-and-hat retailer investors might have expected.
Toss in a beta of 2.22, meaning it moves more than twice as fast as the market, and this stock is clearly wearing rocket shoes.
But here’s the kicker: despite all that momentum, GCO is still trading at just 0.15 times sales. Translation? Investors are paying only 15 cents for every dollar of revenue.
That’s the bargain-bin price tag usually reserved for stocks nobody wants, except this one’s sprinting higher.
Add rising earnings estimates, a solid value profile, and steady cash flow metrics, and you’ve got momentum with a side of underappreciated fundamentals.
The catch? As always, Wall Street will want the rally to be backed by real earnings growth, not just a chart that points up and to the right.
For now, though, GCO appears to be the rare stock delivering speed without the sticker shock.
Airlines
An Airline with Old-School Routes Makes a Futuristic Play
SkyWest (NASDAQ: SKYW) is making waves this week after announcing a strategic investment in Dutch startup Maeve Aerospace, the hybrid-electric hopeful aiming to shake up regional air travel.
The deal gives SkyWest exclusive launch customer rights and a front-row seat in developing next-gen, low-emission aircraft, a flashy move for a carrier known more for reliable regional hops than Silicon Valley-style disruption.
But markets weren’t exactly applauding. Shares slipped 8.2% to $109.42 even as SkyWest bragged about earnings growth, a modernizing fleet, and a $250 million share buyback plan.
The stock’s still up nearly 46% over the past six months, outpacing the entire airline sector, but Wall Street seems to want profit traction to match the electric hype.
With Q3 earnings expected to jump 18.5% and full-year revenue growth forecast in the double digits, investors will be watching whether SkyWest’s green aviation gamble takes flight, or if it’s just another flashy headline before the next turbulence hits.
Early Entry Edge (Sponsored)
The market’s wild swings—like a 427‑point drop one day and a 619‑point rally the next—are enough to make anyone’s head spin.
With Washington trade talks and Fed policy chatter fueling volatility, you need a proven playbook.
Grab our FREE e‑book, Mastering Options Trading: A Beginner’s Guide, and discover:
Market‑proof strategies for up, down, or sideways moves
Smart discount buys to snag top stocks at lower prices
Advanced setups favored by pros for rapid growth
Dividend‑option combos that lock in extra premium
Don’t let this chaos pass you by.
Download your guide now and trade uncertainty like a pro!
Medical Tech
Imaging Player Delivers an Earnings Shock Wall Street Didn’t See Coming
Varex Imaging (NASDAQ: VREX) is making waves this week after posting a shocker of an earnings beat that has investors wondering if the market’s been asleep at the wheel.
The maker of X-ray imaging components delivered Q3 non-GAAP EPS of $0.18, blowing past estimates of $0.04 by a jaw-dropping 800%, even as revenue dipped 3%.
Not exactly the script analysts had in mind for a company facing sector headwinds.
Still, Wall Street’s been slow to jump in. VREX trades at just 12 times earnings and a 0.57 price-to-sales ratio, bargain-bin territory compared to industry averages, while institutional ownership is quietly climbing above 30%.
Add in a 34% gross margin, $8 million in operating cash flow, and analysts calling for nearly 60% earnings growth ahead, and the disconnect gets harder to ignore.
For now, Varex stays stuck in the “show me” camp.
With management guiding for up to $230 million in revenue next quarter and bullish price targets hinting at 67% upside, investors are waiting to see if this under-the-radar imaging player finally gets its moment in the spotlight.
Actionable Picks This Week
A-Mark Precious Metals (NASDAQ: AMRK) is back in the spotlight after posting Q4 net income of $10.3M, or $0.41 per share, as the company wrangles recent acquisitions and scales up logistics automation.
Shares hover around $27, well off last year’s highs but supported by a 2.97% dividend yield and a forward P/E of just 8.4×.
The real story? AMRK’s integrations are hitting their stride, Pinehurst Logistics has been folded into its hub, cost synergies are emerging, and international channels are expanding.
For investors eyeing precious metals exposure with some operating leverage kicker, this week’s results suggest A-Mark might be polishing up for a bigger run.
Eversource Energy (NYSE: ES) is turning heads as value investors zero in on its 13.9× forward earnings and steady dividend wrapped in a utility giant powering New England.
With analysts quietly raising 2025 earnings estimates and the stock holding firm despite market turbulence, the story here isn’t flashy growth; it’s reliable returns in a sector built on consistency.
The company doesn’t flinch through market chaos, earnings surprises keep showing up in the 3% range, and the balance sheet won’t raise anyone’s blood pressure.
No fireworks here... just a stock that grinds higher while the thrill-seekers burn out.
For investors who prefer a steady compounding machine to a lottery ticket, Eversource looks built for the long haul.
Ranger Energy Services (NYSE: RNGR) is in the spotlight this week as value-focused investors zero in on a stock trading at just 10.4× earnings, well below the industry’s 14.5× average.
Add a P/B of 1.1 versus peers at 1.94 and a bargain-bin P/S of 0.52, and the setup screams “undervalued” in a sector where cash flow matters most.
With operating cash flow multiples looking equally cheap, this week’s attention isn’t just about ratios; it’s about timing.
If earnings momentum keeps up, Ranger Energy could be gearing up for a rerating that turns today’s discount into tomorrow’s opportunity.
Market Safety Net (Sponsored)
While most retail traders chase headlines, the smartest investors are quietly moving into safer ground.
They’re targeting 3 overlooked sectors—utilities, staples, and healthcare—that combine income with growth potential.
One yields 8%… another has raised dividends for 54 straight years… and one is redefining healthcare across 2,000+ hospitals.
I’ve broken down all 3 tickers, growth drivers, and entry zones in a free report.
[Access your copy here] before it disappears.
Fast Movers to Watch
BorgWarner (NYSE: BWA) is sitting at $31.50, rocking a 9.3× earnings multiple and a P/B of 1.6 against industry norms of 21.4× and 3.6.
You’re getting a Ferrari engine at used-Honda pricing.
The market keeps snoozing because growth hasn’t gone vertical, but with margins holding and balance sheet muscle under the hood, this sleeper looks primed to roar once investors wake up.Enova International (NASDAQ: ENVA) popped 3.8% to $19.20 this week, stacking an 18% run in 12 weeks with a beta of 1.52. In other words, this thing moves.
Yet at 0.98× sales, it’s still priced like a clearance-rack fintech nobody cares about. The reality is that Enova is quietly expanding in digital lending while competitors trip over regulation and costs.
If momentum meets recognition, this stock could shift from background noise to lead guitar.PROG Holdings (NASDAQ: PRG) nudged up 2.4% to $36.10 this week, quietly catching attention as earnings growth keeps ticking upward.
At 7.1× earnings, that’s like buying front-row tickets for nosebleed prices.
Revenue growth is modest, sure, but consistent execution and fattening margins are doing the heavy lifting.
With management this invested, you’re not betting alone — PRG looks set to graduate from “quiet grinder” to “mainstage act.”
Poll: If you lost your wallet tomorrow, what’s the biggest hassle?
Everything Else
Altice USA is slipping after cost-cutting moves, but investors are buzzing over whether these changes could spark a rebound.
Snap is showing signs of a comeback as digital ad growth lifts spirits, and traders are weighing whether the rally is justified.
Rinnai dipped recently, but the market’s keeping a close eye to see if now’s the time to jump in.
ANI Pharmaceuticals is turning heads this week with 2025 revenue guidance of $818–$843M, sparking chatter about its growth runway and whether the stock’s still under the radar.
That's our coverage for today; thanks for reading! Reply to this email with feedback or any value names you'd like us to dig into.
Best Regards,
—Noah Zelvis
Undervalued Edge
